Loading…

Entrectinib-induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1 -rearranged non-small cell lung cancer

A 75-year-old woman was referred to our hospital because of a productive cough and an abnormal shadow on chest radiography. She was diagnosed as having metastatic lung adenocarcinoma harbouring ROS proto-oncogene 1 ( ). First-line therapy was instituted with entrectinib 600 mg daily, and a gradual d...

Full description

Saved in:
Bibliographic Details
Published in:Respirology case reports 2023-10, Vol.11 (10), p.e01217-n/a
Main Authors: Kato, Chiaki, Sekiya, Muneyuki, Sekiguchi, Ryo, Yamasaki, Akira, Yoshizawa, Takahiro, Isobe, Kazutoshi, Tochigi, Naobumi, Shibuya, Kazutoshi, Kishi, Kazuma
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 75-year-old woman was referred to our hospital because of a productive cough and an abnormal shadow on chest radiography. She was diagnosed as having metastatic lung adenocarcinoma harbouring ROS proto-oncogene 1 ( ). First-line therapy was instituted with entrectinib 600 mg daily, and a gradual decrease in serum sodium level was noticed on day 6, which deteriorated to Grade 3 hyponatremia on day 12. Despite a partial therapeutic response to entrectinib, she developed fatigue and dizziness, so the drug was withdrawn. The clinical findings and laboratory workup were compatible with a diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH) due to entrectinib. The hyponatremia subsequently improved and entrectinib was resumed at a reduced dose of 400 mg daily, which has been continued to date, with no recurrence of SIADH.
ISSN:2051-3380
2051-3380
DOI:10.1002/rcr2.1217